BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2592584)

  • 1. Urinary excretion of prednisolone following intravenous administration in humans.
    al-Habet SM; Rogers HJ
    J Clin Pharmacol; 1989 Oct; 29(10):922-7. PubMed ID: 2592584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of intravenous and oral prednisolone.
    Al-Habet S; Rogers HJ
    Br J Clin Pharmacol; 1980 Nov; 10(5):503-8. PubMed ID: 7437263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of a prednisolone compound in human under normal and pathological conditions.
    Fehér T; Koref O; Tankó A; Bodrogi L; Poteczin E
    Arzneimittelforschung; 1975 Aug; 25(8):1314-7. PubMed ID: 52365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of prednisolone in adrenal insufficiency ].
    von Papen C; Benker G; Hackenberg K; Reinwein D
    Klin Wochenschr; 1982 Jul; 60(13):681-6. PubMed ID: 7120877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute bioavailability of chlorthalidone in man: a cross-over study after intravenous and oral administration.
    Fleuren HL; Thien TA; Verwey-van Wissen CP; van Rossum JM
    Eur J Clin Pharmacol; 1979 Feb; 15(1):35-50. PubMed ID: 421727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and delta1-cortienic acid excretion after intravenous administration of prednisolone and loteprednol etabonate in rats.
    Wu WM; Tang Y; Buchwald P; Bodor N
    Pharmazie; 2010 Jun; 65(6):412-6. PubMed ID: 20614688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
    Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
    Dagrosa EE; Hajdú P; Malerczyk V; de Looze S; Seeger K; Grötsch H
    Clin Ther; 1987; 10(1):18-31. PubMed ID: 3450392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome.
    Frey FJ; Frey BM
    Am J Kidney Dis; 1984 Mar; 3(5):339-48. PubMed ID: 6702820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers.
    Jufer RA; Wstadik A; Walsh SL; Levine BS; Cone EJ
    J Anal Toxicol; 2000 Oct; 24(7):467-77. PubMed ID: 11043648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and kinetics of amlodipine in man.
    Beresford AP; McGibney D; Humphrey MJ; Macrae PV; Stopher DA
    Xenobiotica; 1988 Feb; 18(2):245-54. PubMed ID: 2967593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations.
    Hasselström J; Säwe J
    Clin Pharmacokinet; 1993 Apr; 24(4):344-54. PubMed ID: 8491060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of bethanidine in hypertensive patients.
    Shen D; Gibaldi M; Israili A; Bellward G; Cunningham R; Throne M; Dayton P; McNay J
    Clin Pharmacol Ther; 1975 Mar; 17(3):363-73. PubMed ID: 1120401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
    Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intravenously administration of prednisolone in the horse as determined by radioimmunoassay.
    Chen CL; Goldberg J; Gronwall RR
    Chin J Physiol; 1995; 38(1):1-6. PubMed ID: 8549229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin.
    Smith ML; Shimomura ET; Summers J; Paul BD; Jenkins AJ; Darwin WD; Cone EJ
    J Anal Toxicol; 2001 Oct; 25(7):504-14. PubMed ID: 11599592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration.
    Täuber U; Haack D; Nieuweboer B; Kloss G; Vecsei P; Wendt H
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):48-55. PubMed ID: 6698661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
    Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics and metabolism of fomepizole in healthy humans.
    McMartin KE; Sebastian CS; Dies D; Jacobsen D
    Clin Toxicol (Phila); 2012 Jun; 50(5):375-83. PubMed ID: 22554311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of cotinine after oral and intravenous administration to man.
    De Schepper PJ; Van Hecken A; Daenens P; Van Rossum JM
    Eur J Clin Pharmacol; 1987; 31(5):583-8. PubMed ID: 3830243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.